Biosynex SA operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biosynex SA with three other
pharmaceutical manufacturers in Europe:
Celon Pharma SA
sales of 107.12 million Polish New Zlotys [US$31.82 million]
(35.72 million Euro [US$44.21 million]
based in Spain
(25.28 million Euro [US$31.29 million]
During the year ended December of 2017, sales at
Biosynex SA were 30.50 million Euro (US$37.75 million).
increase of 12.8%
versus 2016, when the company's sales were 27.04 million Euro.
This was the fifth consecutive year of sales increases at Biosynex SA
(and since 2012, sales have increased a total of 1,890%).